Revisiting the concept of cancer stem cells in prostate cancer

Oncogene

Volumn 30, Issue 11, 2011, Pages 1261-1271

  Wang, Z A ^a   Shen, M M ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

cancer stem cell; cell of origin; mouse models; prostate cancer; tumor initiating cell

Indexed keywords

ANDROGEN RECEPTOR;

BASAL CELL; CANCER GROWTH; CANCER RESEARCH; CANCER STEM CELL; FLOW CYTOMETRY; GENETIC ASSOCIATION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; REVIEW;

ANIMALS; EPITHELIAL CELLS; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STEM CELLS;

EID: 79952771880     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.530     Document Type: Review

References (98)

1. Abate-Shen C, Shen MM. (2000). Molecular genetics of prostate cancer. Genes Dev 14: 2410-2434.
2. Abate-Shen C, Shen MM, Gelmann E. (2008). Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogen-esis and carcinogenesis. Differentiation 76: 717-727. (Pubitemid 352032747)
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Prospective identification of tumorigenic breast cancer cells. 100: 3983-3988.
4. Attard G, Cooper CS, de Bono JS. (2009). Steroid hormone receptors in prostate cancer: a hard habit to break? Cancer Cell 16: 458-462.
5. Barabe F, Kennedy JA, Hope KJ, Dick JE. (2007). Modeling the initiation and progression of human acute leukemia in mice. Science 316: 600-604. (Pubitemid 46683146)
6. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M et al. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007. (Pubitemid 350014593)
7. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M et al. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
8. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH et al. (2010). Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6: 25-36.
9. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH et al. (2008). Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 9: R83.
10. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP et al. (2010). Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133-137.
11. Bonkhoff H, Stein U, Remberger K. (1994). The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24: 114-118. (Pubitemid 24109590)
12. Bonkhoff H, Remberger K. (1996). Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98-106. (Pubitemid 26066247)
13. Bonnet D, Dick JE. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hemato-poietic cell. Nat Med 3: 730-737. (Pubitemid 27298715)
14. Burger PE, Xiong X, Coetzee S, Salm SN, Moscatelli D, Goto K et al. (2005). Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. 102: 7180-7185. (Pubitemid 40696354)
15. Chen Y, Sawyers CL, Scher HI. (2008). Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol 8: 440-448.
16. Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G et al. (2008). Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26: 364-371. (Pubitemid 351413596)
17. Clark J, Attard G, Jhavar S, Flohr P, Reid A, De-Bono J et al. (2008). Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 27: 1993-2003. (Pubitemid 351442741)
18. Collins AT, Habib FK, Maitland NJ, Neal DE. (2001). Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)- integrin expression. J Cell Sci 114: 3865-3872. (Pubitemid 33094701)
19. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951. (Pubitemid 41713363)
20. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. (2003). Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 17: 3029-3035. (Pubitemid 38040767)
21. Cunha GR, Lung B. (1978). The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J Exp Zool 205: 181-193.
22. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, Garcia-Echeverria C et al. (2009). The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. 106: 268-273.
23. English HF, Santen RJ, Isaacs JT. (1987). Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11: 229-242. (Pubitemid 18004762)
24. Evans GS, Chandler JA. (1987). Cell proliferation studies in the rat prostate: II The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 11: 339-351. (Pubitemid 18023662)
25. Feil R, Wagner J, Metzger D, Chambon P. (1997). Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237: 752-757. (Pubitemid 27434760)
26. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS et al. (2010). Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70: 491-501.
27. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. (2008). Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. 105: 20882-20887.
28. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. (2010). Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
29. Gu G, Yuan J, Wills M, Kasper S. (2007). Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67: 4807-4815. (Pubitemid 46910189)
30. Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C et al. (2008). Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 21: 1156-1167.
31. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B et al. (2010). Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 42: 668-675.
32. Hill RP. (2006). Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66: 1891-1895, discussion 1890.
33. Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N et al. (2004). MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6: 587-596. (Pubitemid 40017702)
34. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL. (2008). CD44+ CD24(-) prostate cells are early cancer progenitor/ stem cells that provide a model for patients with poor prognosis. Br J Cancer 98: 756-765. (Pubitemid 351272625)
35. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P et al. (1999). Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombi-nases. Nucleic Acids Res 27: 4324-4327. (Pubitemid 29533170)
36. Isaacs JT. (1985). Control of cell proliferation and cell death in the normal and neoplastic prostate: a stem cell model. In: Rodgers CH, Coffey DS, Cunha G, Grayshack JT, Henman R, Horton R (eds). Benign Prostatic Hyperplasia. Department of Health and Human Services: Washington, DC, pp 85-94.
37. Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E et al. (2010). Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 7: 279-282.
38. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J. (2009). Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One 4: e5662.
39. Kurita T, Medina RT, Mills AA, Cunha GR. (2004). Role of p63 and basal cells in the prostate. Development 131: 4955-4964. (Pubitemid 39485353)
40. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres- Cortes J et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648. (Pubitemid 24067706)
41. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON. (2007). Isolation and functional characterization of murine prostate, Stem Cells. 104: 181-186. (Pubitemid 46068005)
42. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. (2010). Basal epithelial stem cells are efficient targets for prostate cancer initiation. 107: 2610-2615.
43. Leong KG, Wang BE, Johnson L, Gao WQ. (2008). Generation of a prostate from a single adult stem cell. Nature 456: 804-808.
44. Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG (2008). PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 68: 1820-1825. (Pubitemid 351416567)
45. Liao CP, Adisetiyo H, Liang M, Roy-Burman P. (2010). Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res 70: 7294-7303.
46. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH et al. (2009). Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-913.
47. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, Ohgi K et al. (2009). Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139: 1069-1083.
48. Mani RS, Tomlins SA, Callahan K, Ghosh A, Nyati MK, Varambally S et al. (2009). Induced chromosomal proximity and gene fusions in prostate cancer. Science 326: 1230.
49. Marotta LL, Polyak K. (2009). Cancer stem cells: a model in the making. Curr Opin Genet Dev 19: 44-50.
50. Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, Kirkali Z, Montironi R. (2008). Rare and unusual histological variants of prostatic carcinoma: clinical significance. BJU Int 102: 1369-1374.
51. Meeker AK, Hicks JL, Platz EA, March GE, Bennett CJ, Delannoy MJ et al. (2002). Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res 62: 6405-6409. (Pubitemid 35364095)
52. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S et al. (2007). Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-3161. (Pubitemid 46724852)
53. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713. (Pubitemid 29197649)
54. Missol-Kolka E, Karbanova J, Janich P, Haase M, Fargeas CA, Huttner WB et al. (2010). Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate (doi:10.1002/pros. 21239).
55. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R et al. (2010). BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7: 403-417.
56. Mosquera JM, Perner S, Genega EM, Sanda M, Hofer MD, Mertz KD et al. (2008). Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res 14: 3380-3385.
57. Mosquera JM, Mehra R, Regan MM, Perner S, Genega EM, Bueti G et al. (2009). Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res 15: 4706-4711.
58. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, Wu H. (2009). Lin-Sca-1+CD49f high stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69: 8555-8562.
59. O'Brien CA, Pollett A, Gallinger S, Dick JE. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110. (Pubitemid 46067310)
60. Passegue E, Wagner EF, Weissman IL. (2004). JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119: 431-443. (Pubitemid 39423844)
61. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. (2005). Side population is enriched in tumorigenic, stemlike cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219. (Pubitemid 40994406)
62. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S et al. (2006). Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
63. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. (2007). Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 67: 6796-6805. (Pubitemid 47105527)
64. Peehl DM. (2005). Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer 12: 19-47. (Pubitemid 40477086)
65. Pfeiffer MJ, Schalken JA. (2010). Stem cell characteristics in prostate cancer cell lines. Eur Urol 57: 246-254.
66. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. (2008). Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
67. Reya T, Morrison SJ, Clarke MF, Weissman IL. (2001). Stem cells, cancer, and cancer stem cells. Nature 414: 105-111. (Pubitemid 33041634)
68. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115. (Pubitemid 46067311)
69. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT. (2004). CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539-3545. (Pubitemid 39206394)
70. Risbridger GP, Taylor RA. (2008). Minireview: regulation of prostatic stem cells by stromal niche in health and disease. Endocrinology 149: 4303-4306.
71. Rosen JM, Jordan CT. (2009). The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673.
72. Shackleton M, Quintana E, Fearon ER, Morrison SJ. (2009). Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822-829.
73. Sharifi N, Kawasaki BT, Hurt EM, Farrar WL. (2006). Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy. Cancer Biol Ther 5: 901-906.
74. Shen MM, Abate-Shen C. (2010). Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 24: 1967-2000.
75. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T et al. (2008). CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120. (Pubitemid 351872330)
76. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L et al. (2000). p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 157: 1769-1775.
77. Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J et al. (2000). Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Histol Histopathol 15: 365-374. (Pubitemid 30218829)
78. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401. (Pubitemid 39551674)
79. Snippert HJ, Haegebarth A, Kasper M, Jaks V, van Es JH, Barker N et al. (2010). Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327: 1385-1389.
80. Spradling AC, Nystul T, Lighthouse D, Morris L, Fox D, Cox R et al. (2008). Stem cells and their niches: integrated units that maintain Drosophila tissues. Cold Spring Harb Symp Quant Biol 73: 49-57.
81. Tang Y, Hamburger AW, Wang L, Khan MA, Hussain A. (2009). Androgen deprivation and stem cell markers in prostate cancers. Int J Clin Exp Pathol 3: 128-138.
82. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11-22.
83. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, Moscatelli D et al. (2002). Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157: 1257-1265. (Pubitemid 34851270)
84. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV et al. (2000). Direct isolation of human central nervous system stem cells. 97: 14720-14725.
85. Ugolkov AV, Eisengart LJ, Luan C, Yang XJ. (2010). Expression analysis of putative stem cell markers in human benign and malignant prostate. Prostate (doi:10.1002/pros.21217).
86. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. (2008). The mammary progenitor marker CD61/ beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 68: 7711-7717.
87. van Leenders G, Dijkman H, Hulsbergen-van de Kaa C, Ruiter D, Schalken J. (2000). Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab Invest 80: 1251-1258. (Pubitemid 30637065)
88. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA. (1988). Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 13: 25-38.
89. Visvader JE. (2009). Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 23: 2563-2577.
90. Wang JC, Dick JE. (2005). Cancer stem cells: lessons from leukemia. Trends Cell Biol 15: 494-501. (Pubitemid 41253469)
91. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H. (2006). Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. 103: 1480-1485.
92. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV et al. (2009). A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461: 495-500.
93. Wei C, Guomin W, Yujun L, Ruizhe Q. (2007). Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol Ther 6: 763-768. (Pubitemid 47328359)
94. Xin L, Ide H, Kim Y, Dubey P, Witte ON. (2003). in vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. 100(Suppl 1): 11896-11903.
95. Xin L, Lawson DA, Witte ON. (2005). The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. 102: 6942-6947.
96. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. (1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718. (Pubitemid 29197650)
97. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D et al. (2008). Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 68: 4674-4682.
98. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT et al. (2009). Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457: 603-607.